Latest news

Thumbnail image for US clears Sanofi’s ‘follow-on’ insulin Admelog

US clears Sanofi’s ‘follow-on’ insulin Admelog

The US Food and Drug Administration has cleared Sanofi's Admelog, the first follow-on biologic version of Eli Lilly’s Humalog, to manage mealtime blood sugar levels in people with diabetes.

12th December 2017

Thumbnail image for Final NHS ‘no’ for obesity pill Mysimba

Final NHS ‘no’ for obesity pill Mysimba

An appeal to get NHS funding for Mysimba as a means for controlling weight has failed, with cost-regulators publishing final guidelines rejecting the drug.

12th December 2017

Thumbnail image for Novartis’ Kymriah shows durable response in blood cancer

Novartis’ Kymriah shows durable response in blood cancer

New analysis of trial data on Novartis’ CAR-T therapy Kymriah presented at the 59th American Society of Hematology (ASH) annual meeting show that the drug sustained complete responses at six months in adults with a difficult to treat form of blood cancer.

11th December 2017

Thumbnail image for NICE u-turn backs combo for kidney cancer

NICE u-turn backs combo for kidney cancer

In a turnaround from its earlier position, the National Institute for Health and Care Excellence is now endorsing NHS funding for Eisai’s Kisplyx plus everolimus for kidney cancer.

11th December 2017

Previous  --   3 4 5 6 7 8 9 10 11 12   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download